Report Detail
Global Pancreatic Cancer Diagnostic Market Growth (Status and Outlook) 2019-2024
- RnM3040486 |
- 28 February, 2019 |
- Global |
- 137 Pages |
- LPI(LP Information) |
- Other
Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. This report studies the Pancreatic Cancer Diagnostic market, includes Tumor Biomarker Tests, Imaging, Biopsy and other products.
United States is the largest sales place, with a consumption value market share nearly 32.12% in 2017. Following United States, Europe is the second largest sales place with the consumption market share of 27.65%.
Market competition is intense. Roche, GE Healthcare, Siemens, BD, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Pancreatic Cancer Diagnostic market will register a 7.9% CAGR in terms of revenue, the global market size will reach US$ 3050 million by 2024, from US$ 1930 million in 2019. In particular, this report presents the global revenue market share of key companies in Pancreatic Cancer Diagnostic business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Pancreatic Cancer Diagnostic market by product type, application, key companies and key regions.
This study considers the Pancreatic Cancer Diagnostic value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Imaging
Tumor Biomarker
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
GE Healthcare
Siemens
BD
Philips Healthcare
Hitachi Medical
Danaher
Abbott
Canon Medical Systems
Myriad Genetics
Qiagen
Asuragen
BioMarker Strategies
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pancreatic Cancer Diagnostic market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pancreatic Cancer Diagnostic market by identifying its various subsegments.
Focuses on the key global Pancreatic Cancer Diagnostic players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pancreatic Cancer Diagnostic with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Pancreatic Cancer Diagnostic submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Pancreatic Cancer Diagnostic Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pancreatic Cancer Diagnostic Market Size 2014-2024
- 2.1.2 Pancreatic Cancer Diagnostic Market Size CAGR by Region
- 2.2 Pancreatic Cancer Diagnostic Segment by Type
- 2.2.1 Imaging
- 2.2.2 Tumor Biomarker
- 2.2.3 Biopsy
- 2.2.4 Other
- 2.3 Pancreatic Cancer Diagnostic Market Size by Type
- 2.3.1 Global Pancreatic Cancer Diagnostic Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Pancreatic Cancer Diagnostic Market Size Growth Rate by Type (2014-2019)
- 2.4 Pancreatic Cancer Diagnostic Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Clinics
- 2.4.3 Others
- 2.5 Pancreatic Cancer Diagnostic Market Size by Application
- 2.5.1 Global Pancreatic Cancer Diagnostic Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Pancreatic Cancer Diagnostic Market Size Growth Rate by Application (2014-2019)
3 Global Pancreatic Cancer Diagnostic by Players
- 3.1 Global Pancreatic Cancer Diagnostic Market Size Market Share by Players
- 3.1.1 Global Pancreatic Cancer Diagnostic Market Size by Players (2017-2019)
- 3.1.2 Global Pancreatic Cancer Diagnostic Market Size Market Share by Players (2017-2019)
- 3.2 Global Pancreatic Cancer Diagnostic Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Pancreatic Cancer Diagnostic by Regions
- 4.1 Pancreatic Cancer Diagnostic Market Size by Regions
- 4.2 Americas Pancreatic Cancer Diagnostic Market Size Growth
- 4.3 APAC Pancreatic Cancer Diagnostic Market Size Growth
- 4.4 Europe Pancreatic Cancer Diagnostic Market Size Growth
- 4.5 Middle East & Africa Pancreatic Cancer Diagnostic Market Size Growth
5 Americas
- 5.1 Americas Pancreatic Cancer Diagnostic Market Size by Countries
- 5.2 Americas Pancreatic Cancer Diagnostic Market Size by Type
- 5.3 Americas Pancreatic Cancer Diagnostic Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Pancreatic Cancer Diagnostic Market Size by Countries
- 6.2 APAC Pancreatic Cancer Diagnostic Market Size by Type
- 6.3 APAC Pancreatic Cancer Diagnostic Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Pancreatic Cancer Diagnostic by Countries
- 7.2 Europe Pancreatic Cancer Diagnostic Market Size by Type
- 7.3 Europe Pancreatic Cancer Diagnostic Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Pancreatic Cancer Diagnostic by Countries
- 8.2 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Type
- 8.3 Middle East & Africa Pancreatic Cancer Diagnostic Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Pancreatic Cancer Diagnostic Market Forecast
- 10.1 Global Pancreatic Cancer Diagnostic Market Size Forecast (2019-2024)
- 10.2 Global Pancreatic Cancer Diagnostic Forecast by Regions
- 10.2.1 Global Pancreatic Cancer Diagnostic Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Pancreatic Cancer Diagnostic Forecast by Type
- 10.8 Global Pancreatic Cancer Diagnostic Forecast by Application
11 Key Players Analysis
- 11.1 Roche
- 11.1.1 Company Details
- 11.1.2 Pancreatic Cancer Diagnostic Product Offered
- 11.1.3 Roche Pancreatic Cancer Diagnostic Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Roche News
- 11.2 GE Healthcare
- 11.2.1 Company Details
- 11.2.2 Pancreatic Cancer Diagnostic Product Offered
- 11.2.3 GE Healthcare Pancreatic Cancer Diagnostic Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 GE Healthcare News
- 11.3 Siemens
- 11.3.1 Company Details
- 11.3.2 Pancreatic Cancer Diagnostic Product Offered
- 11.3.3 Siemens Pancreatic Cancer Diagnostic Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Siemens News
- 11.4 BD
- 11.4.1 Company Details
- 11.4.2 Pancreatic Cancer Diagnostic Product Offered
- 11.4.3 BD Pancreatic Cancer Diagnostic Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 BD News
- 11.5 Philips Healthcare
- 11.5.1 Company Details
- 11.5.2 Pancreatic Cancer Diagnostic Product Offered
- 11.5.3 Philips Healthcare Pancreatic Cancer Diagnostic Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Philips Healthcare News
- 11.6 Hitachi Medical
- 11.6.1 Company Details
- 11.6.2 Pancreatic Cancer Diagnostic Product Offered
- 11.6.3 Hitachi Medical Pancreatic Cancer Diagnostic Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Hitachi Medical News
- 11.7 Danaher
- 11.7.1 Company Details
- 11.7.2 Pancreatic Cancer Diagnostic Product Offered
- 11.7.3 Danaher Pancreatic Cancer Diagnostic Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Danaher News
- 11.8 Abbott
- 11.8.1 Company Details
- 11.8.2 Pancreatic Cancer Diagnostic Product Offered
- 11.8.3 Abbott Pancreatic Cancer Diagnostic Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Abbott News
- 11.9 Canon Medical Systems
- 11.9.1 Company Details
- 11.9.2 Pancreatic Cancer Diagnostic Product Offered
- 11.9.3 Canon Medical Systems Pancreatic Cancer Diagnostic Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Canon Medical Systems News
- 11.10 Myriad Genetics
- 11.10.1 Company Details
- 11.10.2 Pancreatic Cancer Diagnostic Product Offered
- 11.10.3 Myriad Genetics Pancreatic Cancer Diagnostic Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Myriad Genetics News
- 11.11 Qiagen
- 11.12 Asuragen
- 11.13 BioMarker Strategies
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Pancreatic Cancer Diagnostic . Industry analysis & Market Report on Pancreatic Cancer Diagnostic is a syndicated market report, published as Global Pancreatic Cancer Diagnostic Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Pancreatic Cancer Diagnostic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
